Last reviewed · How we verify
NCT03536975: CAREGIVERSPRO
Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers
NA trial testing Platform in Cognitive Impairment, Mild in 48 participants. Completed in 29 April 2019.
29 April 2019
Quick facts
| Lead sponsor | University Hospital, Rouen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 48 |
| Start date | 1 December 2017 |
| Primary completion | 29 April 2019 |
| Estimated completion | 29 April 2019 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Platform — full drug profile →
Conditions studied
- Cognitive Impairment, Mild — all drugs for Cognitive Impairment, Mild →
- Dementia, Mild — all drugs for Dementia, Mild →
Sponsor
University Hospital, Rouen
Who can join
18 and older, any sex, with Cognitive Impairment, Mild or Dementia, Mild. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our main goal is to test a web platform accessible by computers, smartphones and tablets, addressed specifically to caregivers and people with mild cognitive deterioration or mild to moderate dementia providing added value services based on social networks, adapted interventions, clinic strategies and gamification to improve the quality of life of caregivers and people living with dementia (dyads) and permitting to leave in the community as long as possible. To evaluate the platform effectiveness and impact in dementia type disease affected people and caregivers a randomized, controlled, parallel, longitudinal is proposed. The objective will be to assess during 18 months aspects related to health of individuals (general aspect of health, neuropsychological, daily living functionalities, quality of life, treatment adherence, comorbidities ...), social aspects (improving dyad relationship…) and economics (cost-effectiveness of platform utilization), as well as satisfaction degree and usability of platform.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03536975
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Platform
Trials testing the same drug.
- NCT04387734 — Effects of Ocrevus in Relapsing Multiple Sclerosis · Phase 4 · active not recruiting
- NCT03120377 — Efficiency of a Whole Body Vibration Training Program in Adult Renal Transplanted Patients · NA · unknown
Other recruiting trials for Cognitive Impairment, Mild
Currently open trials in the same condition.
- NCT07284446 — Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients · recruiting
- NCT06955494 — ENACT Program on Auditory Perception and Function, Cognitive Function and Health-related Quality of Life · NA · recruiting
- NCT06584110 — Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers · NA · recruiting
- NCT05201534 — Interventions in Mathematics and Cognitive Skills · NA · recruiting
- NCT04262206 — Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults · Phase 4 · recruiting
Other University Hospital, Rouen trials
Trials by the same sponsor.
- NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
- NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
- NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
- NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
- NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03536975 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03536975.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing